PMID- 15041941
OWN - NLM
STAT- MEDLINE
DCOM- 20040520
LR  - 20161026
IS  - 0021-9509 (Print)
IS  - 0021-9509 (Linking)
VI  - 45
IP  - 1
DP  - 2004 Feb
TI  - Comparison between segmentectomy and larger resection of stage IA non-small cell 
      lung carcinoma.
PG  - 67-70
AB  - AIM: Stage IA non small cell lung carcinoma (NSCLC) represents early cancer and 
      is best treated by surgery. The frequency of recurrence and new primary cancer 
      varies from one report to another while the role of sublobar resection is still 
      debated. METHODS: We retrospectively reviewed 121 consecutive patients with 
      pathological stage IA after radical surgery. RESULTS: In stage IA NSCLC 1-, 3-, 
      5-year survival rates were 89%, 76% and 66%. Nearly half of the deaths were 
      unrelated to the original cancer. From statistical analysis we did not find any 
      factor indicative of a better prognosis. We did not find any difference in 
      survival between histologic types. Segmentectomy did not show a worse survival 
      rate compared with larger resection. CONCLUSION: Survival is neither influenced 
      by the type of resection nor by the histologic types in stage IA. However, we 
      noticed a high incidence of local recurrence, segmentectomy could be a viable 
      choice in patients with cardiopulmonary impairment.
FAU - Campione, A
AU  - Campione A
AD  - Department of Thoracic and Cardiovascular Surgery, University Hospital Le Scotte, 
      Siena, Italy.
FAU - Ligabue, T
AU  - Ligabue T
FAU - Luzzi, L
AU  - Luzzi L
FAU - Ghiribelli, C
AU  - Ghiribelli C
FAU - Voltolini, L
AU  - Voltolini L
FAU - Paladini, P
AU  - Paladini P
FAU - Di Bisceglie, M
AU  - Di Bisceglie M
FAU - D'Agata, A
AU  - D'Agata A
FAU - Gotti, G
AU  - Gotti G
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - Italy
TA  - J Cardiovasc Surg (Torino)
JT  - The Journal of cardiovascular surgery
JID - 0066127
SB  - IM
MH  - Adenocarcinoma/mortality/pathology/surgery
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Carcinoma, Adenosquamous/mortality/pathology/surgery
MH  - Carcinoma, Large Cell/mortality/pathology/surgery
MH  - Carcinoma, Non-Small-Cell Lung/mortality/pathology/*surgery
MH  - Carcinoma, Squamous Cell/mortality/pathology/surgery
MH  - Female
MH  - Hospital Mortality
MH  - Hospitals, University
MH  - Humans
MH  - Incidence
MH  - Italy/epidemiology
MH  - Lung Neoplasms/mortality/pathology/*surgery
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Recurrence, Local/epidemiology
MH  - Neoplasm Staging
MH  - Pneumonectomy/adverse effects/*methods
MH  - Prognosis
MH  - Retrospective Studies
MH  - Survival Analysis
MH  - Treatment Outcome
EDAT- 2004/03/26 05:00
MHDA- 2004/05/21 05:00
CRDT- 2004/03/26 05:00
PHST- 2004/03/26 05:00 [pubmed]
PHST- 2004/05/21 05:00 [medline]
PHST- 2004/03/26 05:00 [entrez]
PST - ppublish
SO  - J Cardiovasc Surg (Torino). 2004 Feb;45(1):67-70.